TapewireFind a company

person · Reporting owner

Davis J. E.

Disclosed activity across 1 company

Tapewire entity
2119
SEC CIK
0001599837

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
QUEST DIAGNOSTICS INCDGX · Entity 2118Director · CEO and PresidentSeptember 01, 2026September 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

QUEST DIAGNOSTICS INC

Report date September 01, 2026 · Filed September 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect122,423 Reported balance After 2026-09-01 transaction · row 1
1 source row

Row 1 · 2026-09-01 · Sale · Disposed 10,000 · Balance 122,423

F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Filing footnotes · ownership attribution and instrument terms

F1: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2026 Filed Sep 3, 2026 21:05 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 10,000 $242.72 $2,427,200.00
Disclosure

SEC source: 0001599837-26-000007 · wk-form4_1788469527.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,423

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 22:38 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 10,000 $194.14 $1,941,400.00
Disclosure

SEC source: 0001599837-26-000005 · wk-form4_1780439916.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,423

F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:44 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 26,414 $204.86 $5,411,172.04
Disclosure

SEC source: 0001022079-26-000028 · wk-form4_1772833455.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,423

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

Read SEC document
March 04, 2026 Filed Mar 6, 2026 21:44 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 51,652 $204.86 $10,581,428.72
Disclosure

SEC source: 0001022079-26-000028 · wk-form4_1772833455.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,837

F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:38 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 10,000 $212.52 $2,125,200.00
Disclosure

SEC source: 0001022079-26-000021 · wk-form4_1772660306.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 117,185

F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:38 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 2,968 $204.86 $608,024.48
Disclosure

SEC source: 0001022079-26-000021 · wk-form4_1772660306.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,185

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:11 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 73,225 $0.00 Strike: $204.96 $0.00
Disclosure

SEC source: 0001599837-26-000002 · wk-form4_1771625504.xml · derivative · entry 4

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,225

Underlying: Common Stock · 73,225 shares

Expires 2036-02-18

F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:11 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 3,788 $206.99 $784,078.12
Disclosure

SEC source: 0001599837-26-000002 · wk-form4_1771625504.xml · nonDerivative · entry 3

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,153

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:11 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 2,396 $210.01 $503,183.96
Disclosure

SEC source: 0001599837-26-000002 · wk-form4_1771625504.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,941

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 22:11 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 15,857 $0.00 $0.00
Disclosure

SEC source: 0001599837-26-000002 · wk-form4_1771625504.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,337

F1 · security: Represents an award of restricted stock units.

Read SEC document
November 25, 2025 Filed Nov 28, 2025 21:30 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative 55,093 $95.80 Strike: $95.80 $5,277,633.94
Disclosure

SEC source: 0001022079-25-000233 · wk-form4_1764365447.xml · derivative · entry 5

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 55,093 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F5 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
November 25, 2025 Filed Nov 28, 2025 21:30 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 4,747 $192.97 $916,036.66
Disclosure

SEC source: 0001022079-25-000233 · wk-form4_1764365447.xml · nonDerivative · entry 4

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,480

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $192.820 to $193.310. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 25, 2025 Filed Nov 28, 2025 21:30 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 41,004 $192.27 $7,883,900.59
Disclosure

SEC source: 0001022079-25-000233 · wk-form4_1764365447.xml · nonDerivative · entry 3

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 125,227

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $191.820 to $192.810. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 25, 2025 Filed Nov 28, 2025 21:30 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 9,342 $191.59 $1,789,822.57
Disclosure

SEC source: 0001022079-25-000233 · wk-form4_1764365447.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 166,231

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $190.810 to $191.805. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 25, 2025 Filed Nov 28, 2025 21:30 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Exercise / conversionCommon Stock 55,093 $95.80 $5,277,633.94
Disclosure

SEC source: 0001022079-25-000233 · wk-form4_1764365447.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 175,573

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

Read SEC document
November 05, 2025 Filed Nov 7, 2025 21:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 7,143 $175.57 $1,254,096.51
Disclosure

SEC source: 0001599837-25-000004 · wk-form4_1762550991.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,480

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 453 $169.63 $76,844.20
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 15

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,623

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F16 · price: This transaction was executed in multiple trades at prices ranging from $169.4242 to $169.8209. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 902 $168.79 $152,249.48
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 14

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,076

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F15 · price: This transaction was executed in multiple trades at prices ranging from $168.424 to $169.4178. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 1,493 $167.88 $250,642.75
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 13

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,978

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F14 · price: This transaction was executed in multiple trades at prices ranging from $167.420 to $168.4134. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 267 $169.60 $45,282.45
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 12

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,471

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F13 · price: This transaction was executed in multiple trades at prices ranging from $169.3491 to $169.830. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 584 $168.70 $98,520.27
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 11

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,738

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F12 · price: This transaction was executed in multiple trades at prices ranging from $168.3348 to $169.3269. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 750 $167.86 $125,897.10
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 10

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,322

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F11 · price: This transaction was executed in multiple trades at prices ranging from $167.3341 to $168.334. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 2,493 $169.57 $422,736.02
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 9

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,072

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F10 · price: This transaction was executed in multiple trades at prices ranging from $169.400 to $169.770. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 5,900 $168.66 $995,120.55
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 8

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,565

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F9 · price: This transaction was executed in multiple trades at prices ranging from $168.360 to $169.260. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 6,950 $167.86 $1,166,627.00
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 7

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,465

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F8 · price: This transaction was executed in multiple trades at prices ranging from $167.335 to $168.250. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 2,764 $169.56 $468,662.46
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 6

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,415

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F7 · price: This transaction was executed in multiple trades at prices ranging from $169.3418 to $169.8434. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 4,905 $168.72 $827,563.75
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 5

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,179

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F6 · price: This transaction was executed in multiple trades at prices ranging from $168.3337 to $169.3257. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 7,249 $167.86 $1,216,844.69
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 4

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 155,084

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $167.3326 to $168.3284. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 704 $169.63 $119,416.49
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 3

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,333

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $169.570 to $169.750. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 1,411 $168.76 $238,114.01
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,037

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $168.500 to $169.420. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 02, 2025 Filed Apr 5, 2025 00:29 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 SaleCommon Stock 2,366 $168.03 $397,553.07
Disclosure

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,448

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $167.420 to $168.405. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:37 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 31,656 $173.74 $5,499,913.44
Disclosure

SEC source: 0001022079-25-000090 · wk-form4_1741210635.xml · nonDerivative · entry 3

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,814

F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock awards.

Read SEC document
March 04, 2025 Filed Mar 5, 2025 21:37 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 61,917 $173.74 $10,757,459.58
Disclosure

SEC source: 0001022079-25-000090 · wk-form4_1741210635.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,470

F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock awards approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
March 03, 2025 Filed Mar 5, 2025 21:37 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 1,662 $173.74 $288,755.88
Disclosure

SEC source: 0001022079-25-000090 · wk-form4_1741210635.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,553

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 26, 2025 Filed Feb 28, 2025 21:38 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 2,966 $171.75 $509,410.50
Disclosure

SEC source: 0001022079-25-000075 · wk-form4_1740778717.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,215

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 21:36 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 2,936 $169.71 $498,268.56
Disclosure

SEC source: 0001022079-25-000046 · wk-form4_1740173800.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,181

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:30 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 69,633 $0.00 Strike: $165.30 $0.00
Disclosure

SEC source: 0001022079-25-000038 · wk-form4_1739572222.xml · derivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,633

Underlying: Common Stock · 69,633 shares

Expires 2035-02-12

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 12, 2025 Filed Feb 14, 2025 22:30 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 18,149 $0.00 $0.00
Disclosure

SEC source: 0001022079-25-000038 · wk-form4_1739572222.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,117

F1 · security: Represents an award of restricted stock units.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 21:44 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 1,804 $126.36 $227,953.44
Disclosure

SEC source: 0001022079-24-000080 · wk-form4_1709329445.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,968

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

Read SEC document
February 28, 2024 Filed Mar 1, 2024 21:44 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 3,216 $126.36 $406,373.76
Disclosure

SEC source: 0001022079-24-000080 · wk-form4_1709329445.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 127,772

F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 6,525 $125.02 $815,755.50
Disclosure

SEC source: 0001022079-24-000067 · wk-form4_1709069732.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,988

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

Read SEC document
February 23, 2024 Filed Feb 27, 2024 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 13,390 $125.02 $1,674,017.80
Disclosure

SEC source: 0001022079-24-000067 · wk-form4_1709069732.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,513

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2021, approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
February 21, 2024 Filed Feb 23, 2024 21:35 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 762 $125.02 $95,265.24
Disclosure

SEC source: 0001022079-24-000054 · wk-form4_1708724127.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,123

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

Read SEC document
February 14, 2024 Filed Feb 17, 2024 01:06 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 92,779 $0.00 Strike: $127.81 $0.00
Disclosure

SEC source: 0001022079-24-000036 · wk-form4_1708131954.xml · derivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,779

Underlying: Common Stock · 92,779 shares

Expires 2034-02-14

F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 14, 2024 Filed Feb 17, 2024 01:06 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 22,251 $0.00 $0.00
Disclosure

SEC source: 0001022079-24-000036 · wk-form4_1708131954.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,885

F1 · security: Represents an award of restricted share units.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:31 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 8,036 $147.86 $1,188,202.96
Disclosure

SEC source: 0001022079-23-000065 · wf-form4_167831106431713.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,634

F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:31 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 15,204 $147.86 $2,248,063.44
Disclosure

SEC source: 0001022079-23-000065 · wf-form4_167831106431713.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,670

F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).

Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:34 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 Tax withholdingCommon Stock 1,292 $140.69 $181,771.48
Disclosure

SEC source: 0001022079-23-000040 · wf-form4_167787924588529.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,466

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:56 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantNon-Qualifed Stock Option (right to buy) · Derivative 68,956 $0.00 Strike: $143.33 $0.00
Disclosure

SEC source: 0001022079-23-000038 · wf-form4_167753497328240.xml · derivative · entry 3

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,956

Underlying: Common Stock · 68,956 shares

Expires 2033-02-23

F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.

Read SEC document
February 23, 2023 Filed Feb 27, 2023 21:56 UTC QUEST DIAGNOSTICS INC DGX · Entity 2118 GrantCommon Stock 17,443 $0.00 $0.00
Disclosure

SEC source: 0001022079-23-000038 · wf-form4_167753497328240.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,758

F2 · security: Represents an award of restricted share units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.